{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:44:29Z","timestamp":1790516669613,"version":"4.1.0"},"reference-count":26,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2406,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1600-0404.1995.tb01689.x","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T17:23:12Z","timestamp":1279992192000},"page":"206-212","source":"Crossref","is-referenced-by-count":39,"title":["Clinical characteristics of HTLV-1 associated dermato-polymyositis"],"prefix":"10.1155","volume":"92","author":[{"given":"D.","family":"Smadja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bellance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ph.","family":"Cabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Arfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-C.","family":"Vernant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2009,1,29]]},"reference":[{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(85)92734-5","article-title":"Antibodies to human T-lymphotropic virus type 1 in patients with tropical spastic paraparesis","volume":"ii","author":"Gessain","year":"1985","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-1 associated myelopathy: a new clinical entity","volume":"i","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB3|cit3","unstructured":"WHO wkly Epidem Rec 1989, n\u00b0 49, 382-3. (Report of the scientific group on HTLV-1 infections and associated diseases. Kagoshima, Japan, 10-15 December 1988)"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB4|cit4","first-page":"419","article-title":"Les Parapl\u00e9gies spastiques tropicales en Martinique. Haute pr\u00e9valence d'anticorps HTLV-1","volume":"15","author":"Vernant","year":"1986","journal-title":"Presse M\u00e9dicale"},{"issue":"SUPPI","key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ana.410230743","article-title":"Seroprevalence of antibodies to HTLV-1 in patients with chronic neurological disorders other than tropical spastic paraparesis","volume":"23","author":"Mora","year":"1988","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB6|cit6","first-page":"206","article-title":"Inflammatory myopathy in association with chronic myelopathy in HTLV-1 seropositive patients (abstr)","volume":"30","author":"Goudreau","year":"1988","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0022-510X(92)90012-A","article-title":"Pathological changes in skeletal muscle in HTLV-1-associated myelopathy","volume":"110","author":"Inose","year":"1992","journal-title":"J Neurol Sci"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJM198904133201507","article-title":"Polymyositis in a patient also infected with the immunodeficiency virus","volume":"320","author":"Wiley","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB9|cit9","first-page":"533","volume-title":"HTLV-1 and the nervous system","author":"Monplaisir","year":"1989"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis and inclusion body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0140-6736(89)91793-5","article-title":"HTLV-1 and polymyositis in Jamaica","volume":"ii","author":"Morgan","year":"1989","journal-title":"Lancet"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mus.880150108","article-title":"Failure to detect HTLV-1 by in situ hybridization in the biopsied muscles of viral carriers with polymyositis","volume":"15","author":"Higuchi","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB13|cit13","first-page":"838","article-title":"My\u00e9lopathie, polymyosite et manifestations syst\u00e9miques associ\u00e9es au virus HTLV-1","volume":"145","author":"Masson","year":"1989","journal-title":"Rev Neurol (Paris)"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.410250319","article-title":"Polymyositis and HTLV-1 antibodies (Letter)","volume":"25","author":"Francis","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1212\/WNL.39.12.1572","article-title":"HTLV-1 associated myelopathy and polymyositis in a US native","volume":"39","author":"Evans","year":"1989","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB16|cit16","first-page":"185","article-title":"Dermatomyositis associated with HTLV-1 infection: a case report from Tunisia","volume":"4","author":"Miladi","year":"1992","journal-title":"J Trop Geogr Neurol"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mus.880160207","article-title":"HTLV-1 in acquired adult myopathy","volume":"16","author":"Dickoff","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB18|cit18","first-page":"282","article-title":"Quatre nouvelles observations de neuromyosites, dont un cas associ\u00e9\u00e0 une infection par HTLV-1","volume":"149","author":"Laraki","year":"1993","journal-title":"Rev Neurol (Paris)"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0002-9343(91)90554-B","article-title":"Isolation of HTLV-1 from muscle of a patient with polymyositis","volume":"90","author":"Ishii","year":"1991","journal-title":"Am J Med"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB20|cit20","first-page":"435","volume-title":"HTLV-1 and the nervous system","author":"Tarras","year":"1989"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.410250319","article-title":"Polymyositis and HTLV-1 antibodies (Letter)","volume":"25","author":"Francis","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.410360414","article-title":"Polymyositis in patients infected with Human T-cell Leukemia Virus Type I: the role of the virus in the cause of the disease","volume":"36","author":"Leon-Monzon","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB23|cit23","first-page":"301","article-title":"Immunopathology of HTLV-1 associated-polymyositis (HTLV-1-PM): study in 6 patients","volume":"42","author":"Dalakas","year":"1992","journal-title":"Neurology"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1600-0404.1992.tb08059.x","article-title":"Systemic interferon-alpha in the treatment of HTLV-1-associated myelopathy","volume":"86","author":"Kuroda","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/aid.1991.7.1031","article-title":"Tropical Spastic Paraparesis\/HTLV-1-Associated Myelopathy (TSP\/HAM): treatment with an anabolic steroid danazol","volume":"7","author":"Harrington","year":"1991","journal-title":"AIDS Res Hum Ret"},{"key":"10.1111\/j.1600-0404.1995.tb01689.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/jnnp.56.11.1213","article-title":"Intermittent high-dose vitamin C therapy in patients with HTLV-1-associated myelopathy (HAM)","volume":"56","author":"Kataoka","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.1995.tb01689.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0404.1995.tb01689.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:46:18Z","timestamp":1671540378000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0404.1995.tb01689.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,29]]},"references-count":26,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1600-0404.1995.tb01689.x","relation":{},"ISSN":["0001-6314","1600-0404"],"issn-type":[{"value":"0001-6314","type":"print"},{"value":"1600-0404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,29]]}}}